Medtronic CEO Geoff Martha discusses innovations such as pulse field ablation, renal denervation, DBS, TAVR, diabetes tech ...

Medtronic MDT has started the year 2025 on a positive note, with the stock climbing nearly 7% so far in January. This surge in market optimism follows the CMS' recent move to initiate a national ...

Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...